Conquering melanoma and skin cancer
Melanoma and Skin Cancer Trials specialises in investigator-initiated melanoma and skin cancer research.
We work collaboratively with world-leading researchers to deliver clinical trials that improve melanoma and skin cancer outcomes.
Since 1999, we have delivered melanoma and skin cancer clinical trials
Trials
Investigators
Worldwide
Countries
Patients
Enrolled
Donate to conquer melanoma and skin cancer
Every year, 18,000+ Australians are diagnosed with invasive melanoma and over 1,400 Australians will lose their life to this deadly cancer that can affect young and old.
Please donate today and help us conquer melanoma and skin cancer through clinical trials.
What We Do
Melanoma and Skin Cancer Trials Ltd works with world-leading researchers to deliver clinical trials that improve melanoma and skin cancer outcomes. We are the only independent, not-for-profit, multi-site, collaborative clinical trials group focused on melanoma and skin cancer in Australia and New Zealand.
From early engagement with consumers and researchers to develop research concepts, through to the publication of results, we work cooperatively to provide a range of clinical trial services.

LATEST NEWS

Trial offering new treatment combination for melanoma brain metastases opens at Alfred Health
Led by MASC Trials and Dr Malaka Ameratunga, the BETTER trial aims to improve the care, treatment and quality of life for symptomatic patients with melanoma that has spread to the brain.

Leading skin care company lends its support to melanoma and skin cancer clinical trials
To help conquer the urgent problem Australia has with melanoma and skin cancer, leading skin care brand Avène has teamed up with Melanoma and Skin Cancer Trials.

Conquering Skin Cancer: Award Wins and More Screenings!
The incredible efforts of the team behind Conquering Skin Cancer were recognised at the 2025 Impact DOCS Awards with Awards of Excellence for Best Documentary Feature and Best Direction. There are also new screening locations and sessions to be held in in South Australia and New South Wales.